Advertisement

Experimental treatment borrowed from blood cancer shows promise for pediatric brain tumors

An experimental version of CAR-T therapy doubled the survival time for children a deadly and aggressive form of brain cancer called DIPG.

Leave a Reply

Your email address will not be published. Required fields are marked *